✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
The generic ingredient in TACE is chlorotrianisene. There are four drug master file entries for this compound. Additional details are available on the chlorotrianisene profile page.
Profile for product number 004
|Approval Date:||Approved Prior to Jan 1, 1982||TE:||RLD:||No|
Complete Access Available with Subscription